Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)
Clinical trial NCT00566527 · COMPLETED
Trial details
- NCT number
- NCT00566527
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-29
- Primary completion
- 2008-12-29
- Enrollment
- 1620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.